JENNIFER MEITZNER: Open Payments
NPI 1154515203 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,590 in 154 payments from 18 companies in 2025. Trend: 2023 $2,491 · 2024 $2,877 · 2025 $2,590
Food & beverage: $2,355Education: $236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $281 |
| Novartis Pharmaceuticals Corporation | 13 | $258 |
| Galderma Laboratories, L.P. | 27 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $242 |
| E.R. Squibb & Sons, L.L.C. | 10 | $223 |
| UCB, Inc. | 11 | $200 |
| Amgen Inc. | 12 | $196 |
| Janssen Biotech, Inc. | 10 | $187 |
| PFIZER INC. | 11 | $149 |
| Regeneron Healthcare Solutions, Inc. | 8 | $143 |
Products named: COSENTYX, DUPIXENT, Sotyktu, Bimzelx, OTEZLA, TREMFYA, NEMLUVIO, CIBINQO.
Industry payments across MI — which companies pay providers there.
